Camille Sureau Selected Research

Camille Sureau Research Topics

Disease

32	Infections 10/2023 - 12/2006
8	Hepatitis B 04/2023 - 01/2009
6	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 01/2012
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2019
3	Neoplasms (Cancer) 03/2021 - 01/2016
3	Viremia 10/2020 - 01/2017
2	Fibrosis (Cirrhosis) 03/2021 - 01/2018
2	Coinfection 01/2020 - 01/2019
2	Liver Diseases (Liver Disease) 01/2018 - 01/2016
2	Reinfection 12/2015 - 02/2013
1	COVID-19 03/2021
1	Insulin Resistance 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Hepatitis D 10/2018
1	Hepatitis 01/2018
1	Chronic Hepatitis B 04/2016

Drug/Important Bio-Agent (IBA)

9	Antiviral Agents (Antivirals)IBA 03/2021 - 12/2015
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2006
5	sodium-bile acid cotransporterIBA 01/2021 - 12/2015
4	AntibodiesIBA 04/2023 - 01/2008
4	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2008
4	InterferonsIBA 01/2018 - 10/2016
3	Nucleic AcidsIBA 01/2018 - 01/2017
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018 - 01/2009
3	PolymersIBA 01/2018 - 01/2017
2	OxysterolsIBA 10/2023 - 03/2021
2	VaccinesIBA 04/2023 - 02/2013
2	Hepatitis delta Antigens (HDAg)IBA 01/2019 - 10/2018
2	Amino Acids FDA Link 01/2019 - 12/2009
2	Peptides (Polypeptides)IBA 01/2019 - 01/2018
2	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 01/2018 - 01/2017
2	entecavir FDA Link 01/2018 - 01/2017
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017 - 01/2016
2	Hepatitis B e AntigensIBA 12/2016 - 01/2016
1	Synthetic Vaccines (Recombinant Vaccines)IBA 04/2023
1	GeneVac BIBA 04/2023
1	Engerix-BIBA 04/2023
1	Immunoglobulins (Immunoglobulin)IBA 04/2023
1	Alitretinoin FDA Link 01/2022
1	Bexarotene (LGD1069)FDA Link 01/2022
1	LuciferasesIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	KinesinsIBA 01/2022
1	exophillic acidIBA 01/2022
1	CholesterolIBA 03/2021
1	Broadly Neutralizing AntibodiesIBA 10/2020
1	Viral AntigensIBA 01/2020
1	Estrogen Receptor alphaIBA 01/2020
1	GlycosaminoglycansIBA 01/2020
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	EpitopesIBA 01/2020
1	pyrimidineIBA 01/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	myrcludex-BIBA 01/2019
1	Protein SIBA 10/2018
1	LigandsIBA 01/2018
1	REP 2139IBA 01/2018
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2018
1	Tenofovir (Viread)FDA Link 01/2018
1	Troglitazone (Rezulin)FDA Link 01/2018
1	Surface Antigens (Surface Antigen)IBA 01/2018
1	CoumarinsIBA 01/2018
1	EnzymesIBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	OligonucleotidesIBA 01/2017
1	proanthocyanidinIBA 01/2017
1	Interferon-alpha (Interferon Alfa)IBA 01/2017
1	Hepatitis B virus P proteinIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 12/2016
1	Bile Acids and Salts (Bile Acids)IBA 10/2016
1	Therapeutic UsesIBA 04/2016
1	Monoclonal AntibodiesIBA 04/2016
1	GlypicansIBA 01/2016
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2016
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2016
1	vanitaracin AIBA 12/2015
1	PolyketidesIBA 12/2015
1	PF-429242IBA 03/2015
1	Ritonavir (Norvir)FDA Link 06/2014
1	Irbesartan FDA LinkGeneric 06/2014
1	Ezetimibe (Zetia)FDA Link 06/2014
1	Proteoglycans (Proteoglycan)IBA 03/2013
1	Alanine (L-Alanine)FDA Link 03/2013
1	Heparin (Liquaemin)FDA LinkGeneric 03/2013
1	Heparitin Sulfate (Heparan Sulfate)IBA 03/2013
1	Blood Group Antigens (Blood Groups)IBA 01/2012
1	TetraspaninsIBA 01/2008
1	DisulfidesIBA 12/2007
1	Sulfhydryl Compounds (Thiols)IBA 12/2007

Therapy/Procedure

7	Therapeutics 12/2021 - 01/2009
1	Aftercare (After-Treatment) 01/2018